Rocket Pharma increases authorized shares to 180M after shareholder approval

ROCKET PHARMACEUTICALS, INC.

Authorized common shares increased from 120M to 180M (50% increase); amendment effective June 20, 2024.
All ten director nominees elected; highest vote totals over 71M 'for' votes.
Ratification of EisnerAmper as independent auditor for FY 2024 approved by ~99.9% of votes cast.
Non-binding advisory vote on named executive officer compensation passed with ~98.4% of votes cast.
Voter turnout approximately 87.95% of outstanding shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.